The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AKERO THERAPEUTICS INC | COM | 00973Y108 | 33,129,011 | 604,544 | SH | SOLE | 604,544 | 0 | 0 | |||
ALPINE IMMUNE SCIENCES INC | COM | 02083G100 | 17,034,610 | 2,317,634 | SH | SOLE | 2,317,634 | 0 | 0 | |||
ARCELLX INC | COMMON STOCK | 03940C100 | 27,327,489 | 882,101 | SH | SOLE | 882,101 | 0 | 0 | |||
ARGENX SE | SPONSORED ADR | 04016X101 | 33,926,499 | 89,556 | SH | SOLE | 89,556 | 0 | 0 | |||
ARVINAS INC | COM | 04335A105 | 20,512,282 | 599,599 | SH | SOLE | 599,599 | 0 | 0 | |||
ASCENDIS PHARMA A/S | SPONSORED ADR | 04351P101 | 43,088,441 | 352,808 | SH | SOLE | 352,808 | 0 | 0 | |||
BICYCLE THERAPEUTICS PLC | SPONSORED ADS | 088786108 | 36,505,088 | 1,233,280 | SH | SOLE | 1,233,280 | 0 | 0 | |||
BIOGEN INC | COM | 09062X103 | 66,120,742 | 238,772 | SH | SOLE | 238,772 | 0 | 0 | |||
CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 16,288,922 | 890,105 | SH | SOLE | 890,105 | 0 | 0 | |||
HORIZON THERAPEUTICS PUB L | SHS | G46188101 | 54,349,173 | 477,585 | SH | SOLE | 477,585 | 0 | 0 | |||
IMMUNOCORE HLDGS PLC | ADS | 45258D105 | 48,961,780 | 857,925 | SH | SOLE | 857,925 | 0 | 0 | |||
INCYTE CORP | COM | 45337C102 | 68,499,306 | 852,830 | SH | SOLE | 852,830 | 0 | 0 | |||
KARUNA THERAPEUTICS INC | COM | 48576A100 | 20,870,265 | 106,210 | SH | SOLE | 106,210 | 0 | 0 | |||
LEGEND BIOTECH CORP | SPONSORED ADS | 52490G102 | 52,659,110 | 1,054,870 | SH | SOLE | 1,054,870 | 0 | 0 | |||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 57,451,721 | 1,267,970 | SH | SOLE | 1,267,970 | 0 | 0 | |||
POSEIDA THERAPEUTICS INC | COM | 73730P108 | 12,904,525 | 2,434,816 | SH | SOLE | 2,434,816 | 0 | 0 | |||
PROTHENA CORP PLC | SHS | G72800108 | 4,518,750 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | |||
SEAGEN INC | COM | 81181C104 | 36,790,871 | 286,288 | SH | SOLE | 286,288 | 0 | 0 | |||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 49,742,330 | 1,954,512 | SH | SOLE | 1,954,512 | 0 | 0 | |||
UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | 41,405,376 | 148,892 | SH | SOLE | 148,892 | 0 | 0 | |||
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 51,151,588 | 1,751,167 | SH | SOLE | 1,751,167 | 0 | 0 | |||
VOR BIOPHARMA INC | COM | 929033108 | 42,844,786 | 6,442,825 | SH | SOLE | 6,442,825 | 0 | 0 | |||
ZAI LAB LTD | ADR | 98887Q104 | 15,818,912 | 515,274 | SH | SOLE | 515,274 | 0 | 0 |